Pfizer

Pfizer Shares Face Mixed Signals as Oncology Setback Overshadows Dermatology Advance

March 10, 2026

Navigating a Transition: Pfizer’s Strategic Pivot Amidst Financial Headwinds

March 9, 2026

Pfizer Charts a Post-Pandemic Course Beyond Covid Revenues

kashif hafeez - March 3, 2026

Pfizer Faces Mounting Pressure from Key Patent Expirations

kashif hafeez - February 21, 2026

Institutional Investors Signal Confidence in Pfizer Amid Market Uncertainty

February 19, 2026

Pfizer Investors Await Crucial Strategy Update Amid Looming Patent Expirations

angelina - December 6, 2025

Pfizer Stock: A Contrarian Bet Amidst Market Uncertainty

angelina - December 4, 2025

Pfizer Shares Positioned for Significant Upswing

angelina - November 28, 2025

Pfizer Shares Gain Momentum as Analysts and Institutions Show Confidence

Brett Shapiro - November 28, 2025

Pfizer Shares Show Signs of Recovery After Key Regulatory Win

kashif hafeez - November 24, 2025

Acquisition Battle Intensifies for Pfizer in Obesity Drug Arena

October 31, 2025